These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 26831104)

  • 1. TLR4/MD-2 activation by a synthetic agonist with no similarity to LPS.
    Wang Y; Su L; Morin MD; Jones BT; Whitby LR; Surakattula MM; Huang H; Shi H; Choi JH; Wang KW; Moresco EM; Berger M; Zhan X; Zhang H; Boger DL; Beutler B
    Proc Natl Acad Sci U S A; 2016 Feb; 113(7):E884-93. PubMed ID: 26831104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Funiculosin variants and phosphorylated derivatives promote innate immune responses via the Toll-like receptor 4/myeloid differentiation factor-2 complex.
    Okamoto N; Mizote K; Honda H; Saeki A; Watanabe Y; Yamaguchi-Miyamoto T; Fukui R; Tanimura N; Motoi Y; Akashi-Takamura S; Kato T; Fujishita S; Kimura T; Ohto U; Shimizu T; Hirokawa T; Miyake K; Fukase K; Fujimoto Y; Nagai Y; Takatsu K
    J Biol Chem; 2017 Sep; 292(37):15378-15394. PubMed ID: 28754693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin tolerance.
    Rajaiah R; Perkins DJ; Ireland DD; Vogel SN
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8391-6. PubMed ID: 26106158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of toll-like receptors in changes in gene expression and NF-kappa B activation in mouse hepatocytes stimulated with lipopolysaccharide.
    Liu S; Gallo DJ; Green AM; Williams DL; Gong X; Shapiro RA; Gambotto AA; Humphris EL; Vodovotz Y; Billiar TR
    Infect Immun; 2002 Jul; 70(7):3433-42. PubMed ID: 12065483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfatides are endogenous ligands for the TLR4-MD-2 complex.
    Su L; Athamna M; Wang Y; Wang J; Freudenberg M; Yue T; Wang J; Moresco EMY; He H; Zor T; Beutler B
    Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34290146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pellino-1 Positively Regulates Toll-like Receptor (TLR) 2 and TLR4 Signaling and Is Suppressed upon Induction of Endotoxin Tolerance.
    Murphy M; Xiong Y; Pattabiraman G; Qiu F; Medvedev AE
    J Biol Chem; 2015 Jul; 290(31):19218-32. PubMed ID: 26082489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide (LPS)-binding protein stimulates CD14-dependent Toll-like receptor 4 internalization and LPS-induced TBK1-IKKϵ-IRF3 axis activation.
    Tsukamoto H; Takeuchi S; Kubota K; Kobayashi Y; Kozakai S; Ukai I; Shichiku A; Okubo M; Numasaki M; Kanemitsu Y; Matsumoto Y; Nochi T; Watanabe K; Aso H; Tomioka Y
    J Biol Chem; 2018 Jun; 293(26):10186-10201. PubMed ID: 29760187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.
    Yamamoto M; Sato S; Hemmi H; Hoshino K; Kaisho T; Sanjo H; Takeuchi O; Sugiyama M; Okabe M; Takeda K; Akira S
    Science; 2003 Aug; 301(5633):640-3. PubMed ID: 12855817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gedunin Binds to Myeloid Differentiation Protein 2 and Impairs Lipopolysaccharide-Induced Toll-Like Receptor 4 Signaling in Macrophages.
    Borges PV; Moret KH; Maya-Monteiro CM; Souza-Silva F; Alves CR; Batista PR; Caffarena ER; Pacheco P; Henriques Md; Penido C
    Mol Pharmacol; 2015 Nov; 88(5):949-61. PubMed ID: 26330549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
    Mishra V; Pathak C
    J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular events mediated by lipopolysaccharide-stimulated toll-like receptor 4. MD-2 is required for activation of mitogen-activated protein kinases and Elk-1.
    Yang H; Young DW; Gusovsky F; Chow JC
    J Biol Chem; 2000 Jul; 275(27):20861-6. PubMed ID: 10877845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFκB signaling, MAPK, and Jak1/Stat1 pathways.
    Gorina R; Font-Nieves M; Márquez-Kisinousky L; Santalucia T; Planas AM
    Glia; 2011 Feb; 59(2):242-55. PubMed ID: 21125645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique properties of the chicken TLR4/MD-2 complex: selective lipopolysaccharide activation of the MyD88-dependent pathway.
    Keestra AM; van Putten JP
    J Immunol; 2008 Sep; 181(6):4354-62. PubMed ID: 18768894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex.
    Youn HS; Lee JY; Fitzgerald KA; Young HA; Akira S; Hwang DH
    J Immunol; 2005 Sep; 175(5):3339-46. PubMed ID: 16116226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum amyloid A3 binds MD-2 to activate p38 and NF-κB pathways in a MyD88-dependent manner.
    Deguchi A; Tomita T; Omori T; Komatsu A; Ohto U; Takahashi S; Tanimura N; Akashi-Takamura S; Miyake K; Maru Y
    J Immunol; 2013 Aug; 191(4):1856-64. PubMed ID: 23858030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP.
    Andreakos E; Sacre SM; Smith C; Lundberg A; Kiriakidis S; Stonehouse T; Monaco C; Feldmann M; Foxwell BM
    Blood; 2004 Mar; 103(6):2229-37. PubMed ID: 14630816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycyrrhizin and isoliquiritigenin suppress the LPS sensor toll-like receptor 4/MD-2 complex signaling in a different manner.
    Honda H; Nagai Y; Matsunaga T; Saitoh S; Akashi-Takamura S; Hayashi H; Fujii I; Miyake K; Muraguchi A; Takatsu K
    J Leukoc Biol; 2012 Jun; 91(6):967-76. PubMed ID: 22422925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C4b-binding protein negatively regulates TLR4/MD-2 response but not TLR3 response.
    Morita N; Yamazaki T; Murakami Y; Fukui R; Yamai I; Ichimonji I; Nakashima A; Nagaoka F; Takagi H; Miyake K; Akashi-Takamura S
    FEBS Lett; 2017 Jun; 591(12):1732-1741. PubMed ID: 28542817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tailored Modulation of Cellular Pro-inflammatory Responses With Disaccharide Lipid A Mimetics.
    Heine H; Adanitsch F; Peternelj TT; Haegman M; Kasper C; Ittig S; Beyaert R; Jerala R; Zamyatina A
    Front Immunol; 2021; 12():631797. PubMed ID: 33815382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of MyD88 and TLR4 in the LPS-mimetic activity of Taxol.
    Byrd-Leifer CA; Block EF; Takeda K; Akira S; Ding A
    Eur J Immunol; 2001 Aug; 31(8):2448-57. PubMed ID: 11500829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.